Frost & Sullivan is invited to attend the 2022 China Healthcare Leaders Summit and the China Pharmaceutical Distribution Industry Supply-Side Structural Reform and Innovation Forum

Frost & Sullivan is invited to attend the 2022 China Healthcare Leaders Summit and the China Pharmaceutical Distribution Industry Supply-Side Structural Reform and Innovation Forum

2022/09/21

2022year9month20day-21On the day, co-hosted by the China Pharmaceutical Business Association, the China Chemical Pharmaceutical Industry Association, the China Traditional Chinese Medicine Association, and Sinopharm Exhibition & Convention Co., Ltd., “2022The 'China Healthcare Leaders Summit & China Pharmaceutical Distribution Industry Supply-Side Structural Reform and Innovation Forum' was held in Shanghai. With the theme of 'Revitalization & Symbiosis', this conference conducted a profound analysis and interpretation of aspects such as 'the reform of the medical security system during the 14th Five-Year Plan period' and 'opportunities and challenges brought by deepening healthcare reform to the market'; it also explored in depth the differentiated business layout of enterprises and the innovative changes in the pharmaceutical supply chain; and analyzed and assessed the future development trends of the pharmaceutical distribution industry in areas such as medical devices, innovative high-value drugs, and special medical foods.



Frost & SullivanFrost & SullivanLi Qian, Senior Consulting Director for Healthcare in Greater China at Frost & Sullivan (referred to as 'Frost & Sullivan'), was invited to attend the conference and delivered a speech on the analysis of the Chinese healthcare market and popular sectors.


Senior Consulting Director, Healthcare, Frost & Sullivan Greater China Li Qian



 Li Qian pointed out that after entering the '13th Five-Year Plan' period, China has elevated 'Healthy China' to a national strategy, and the big health industry has begun to develop rapidly.   Data shows that the market scale of China's big health industry2017year6.52trillion yuan, increasing to2021year9.23trillion yuan2017 - 2021year after9.1%The annual compound growth rate has been rapidly accelerating. Among them, the proportion of the medical service market56.4%It is the largest sub-market within the large health market segmentation field.


 In recent years, the large health market has gradually differentiated. Apart from the medical services market, which is the largest in scale, the markets for medical devices and consumer healthcare have grown relatively rapidly.  It is expected that under the trends of a beauty economy and enhanced residents' purchasing power, residents' demand for healthcare products and services with stronger consumer attributes will continue to increase. In the future, the demand in the consumer healthcare market will be further unleashed. 



According to a study by Frost & Sullivan, driven by favorable policies and residents' health needs, China's large health industry structure has been gradually optimized. Under the current policy orientation of healthcare cost control and import substitution, domestic innovative drugs and medical devices are developing rapidly. At the same time, capital from home and abroad pouring into China's large health market will accelerate the development of emerging fields such as innovative drugs, consumer healthcare, and digital healthcare.  In the future, China's large health market will develop into an industrial model led by technology and products, with services as an important means.


 Subsequently, Li Qian focused on the popular segment of consumer healthcare - the medical aesthetics market. Consumer healthcare is a competitive sector that combines 'consumption' and 'medical' attributes. Li Qian believes that under the general trend of consumption upgrading, there is a vast potential consumer base in the consumer healthcare market.2017 - 2021The annual compound growth rate of the consumer healthcare market is15.5%,2021Nearly reached9One trillion yuan.



 The consumer healthcare market is primarily targeted at young people and high-income groups. Consumers expect to improve their appearance and health through consumption of healthcare products. The entire consumer healthcare market exhibits high average transaction value per customer, high profit margins, and

Finally, Li Qian summarized the future development trends of the medical aesthetics industry. She stated:   1With stricter regulation and industry integration, the medical beauty market will return to formal institutions and projects in the future, leading to a healthier and more orderly development of the industry;   2)   Consumers' understanding of medical aesthetics will gradually deepen, and their consumption decisions will become more mature and rational. They will tend to choose professional medical aesthetic institutions that are regular in operation, provide high-quality services, and have a good reputation;   3With the large-scale growth of the medical beauty market, specialized medical beauty institutions and departments will develop rapidly, providing consumers with more professional, comprehensive, and full-cycle medical beauty solutions;   4The continuous iteration of non-surgical medical aesthetics technologies has provided consumers with diverse choices, helping institutions develop highlight projects, acquire customers, and accelerate expansion. Non-surgical medical aesthetics projects will redefine the medical aesthetics market.



 "The market will be further standardized under the impetus of strong supervision, and in the future, it will provide consumers with more professional and diversified services." Li Qian said.

Characteristics of dependent marketing.


 In the entire consumer healthcare market, the medical aesthetics market has a large scale and rapid growth rate. Among them, non-surgical medical aesthetic projects are gradually favored by consumers due to their low unit price, minimal trauma, short recovery period, and low risk. The attribute of repeat consumption makes the market demand huge, thus leading to rapid growth in the market share of medical aesthetics. Data shows the scale of China's medical aesthetics market2017 - 2021The compound annual growth rate reaches17.5%Among them, the market scale of non-surgical medical beauty projects achieved a compound annual growth rate of24.9%, is expected to arrive2026The year will grow to4one trillion yuan2030Year is coming6.4One trillion yuan.



 "With the implementation of various policies, the medical aesthetics industry has entered an era of strong regulation. In the future, a sound regulatory mechanism will promote the standardized and rapid development of the market."   Li Qian further explained,2021In [year], eight departments including the National Health Commission issued the 'Notice on Printing and Distributing the Special Rectification Work Plan for Combating Illegal Medical Beauty Services', launching a nationwide special rectification campaign against illegal medical beauty services. This campaign aims to severely crack down on activities related to illegal medical beauty, standardize medical beauty services, and combat the illegal production and sale of drugs and medical devices. In the same year, the State Administration for Market Regulation issued the 'Medical Beauty Advertising Law Enforcement Guidelines (Draft for Soliciting Opinions)', requiring the rectification of various medical beauty advertising anomalies, focusing on solving problems that pose significant hazards and are highly reflected by the public, and strictly regulating the endorsement behavior of industry personnel.

Finally, Li Qian summarized the future development trends of the medical aesthetics industry. She stated:   1With stricter regulation and industry integration, the medical beauty market will return to formal institutions and projects in the future, leading to a healthier and more orderly development of the industry;   2)   Consumers' understanding of medical aesthetics will gradually deepen, and their consumption decisions will become more mature and rational. They will tend to choose professional medical aesthetic institutions that are regular in operation, provide high-quality services, and have a good reputation;   3With the large-scale growth of the medical beauty market, specialized medical beauty institutions and departments will develop rapidly, providing consumers with more professional, comprehensive, and full-cycle medical beauty solutions.   4The continuous iteration of non-surgical medical aesthetics technologies has provided consumers with diverse choices, helping institutions develop highlight projects, acquire customers, and accelerate expansion. Non-surgical medical aesthetics projects will redefine the medical aesthetics market.



 "The market will be further standardized under the impetus of strong regulation, and in the future, it will provide consumers with more professional and diversified services." Li Qian said.


联系我们
联系我们
电话

业务咨询热线

(021)54075836

微信
二维码

扫码关注官方微信公众号

返回顶部
返回顶部

联系我们

×
请选择职位类别
请选择
×